A systematic review through November 2025 (PubMed, Web of Science, Scopus, ScienceDirect) identified 27 eligible studies evaluating azathioprine exposure and posttransplant skin cancer risk. Pooled ...
Comparing metagenomic profiles of the skin microbiome in immunosuppressed patients and those at high and low risk for cutaneous squamous cell carcinoma (SCC) revealed distinct expansions in fungal and ...
Skin cancer is the most common cancer in the U.S. Learn the main types, warning signs, and the prevention tip dermatologists ...
Skin malignancies are the most common cancers in the United States. 1 Typically, skin cancer is categorized as either melanoma or nonmelanoma skin cancer, which is also known as keratinocyte ...
There are three common types of skin cancer in the United States: basal cell carcinoma, squamous cell carcinoma and melanoma. Merkel cell carcinoma is a rare type of skin cancer. Fred Hutch Cancer ...
The C-POST trial showed a disease-free survival benefit with adjuvant Libtayo for high-risk cutaneous squamous cell carcinoma, potentially influencing future standard care. Immunotherapy remains the ...
Libtayo's FDA approval offers an effective adjuvant option for high-risk cutaneous squamous cell carcinoma, reducing recurrence risk by 68% in the C-POST trial. Administered post-surgery and radiation ...
Checkpoint Therapeutics, Inc. announced that the FDA has approved UNLOXCYT™ (cosibelimab-ipdl) for treating adults with metastatic cutaneous squamous cell carcinoma (cSCC) or locally advanced cSCC who ...
See how Specialists in Dermatology in The Woodlands and Houston achieves a 99% skin cancer cure rate with Mohs surgery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results